Introduction: Why Is Impurity Control in Antipsychotic Drugs More Stringent?
Introduction: Why Is Impurity Control in Antipsychotic Drugs More Stringent?
Antipsychotic drugs can be classified into two categories based on receptor mechanisms. Typical antipsychotics (FGAs, first-generation), represented by haloperidol, primarily act by blocking central dopamine D2 receptors, but are prone to causing extrapyramidal side effects and other adverse reactions. Atypical antipsychotics (SGAs, second-generation), represented by ziprasidone and paliperidone, exhibit dual antagonism of 5-HT2A and D2 receptors, effectively relieving positive symptoms and to some extent improving negative symptoms. Compared with FGAs, SGAs cause fewer extrapyramidal reactions but are more likely to induce metabolic syndrome and other adverse effects.
Psychiatric disorders require long-term medication, leading to cumulative dosing and elevated risks of specific adverse reactions. The long-term safety risks posed by impurities cannot be ignored. Antipsychotic drugs mostly feature polycyclic heterocyclic structures, long synthetic routes, and harsh reaction conditions, making them prone to generating process-related impurities. They are easily oxidized and sensitive to light, acids, and alkalis, with complex degradation pathways. At the same time, some impurities may carry mutagenic risks; impurity limit setting requires toxicological assessment. The availability of comprehensive reference standards and structural confirmation forms the foundation for impurity profiling论证 in related substance method development and submission dossiers.
As a professional supplier deeply engaged in the impurity reference standard field, Sinco focuses this issue on two core drugs in the psychiatric nervous system, covering impurity projects for Paliperidone and Ziprasidone, providing full sets of compliance spectra to offer traceable reference support for your impurity research.
Star Products of This Issue
SGAs: Ziprasidone Impurities
[Common Challenges] The synthesis end stage under high-temperature and strong-alkali conditions easily generates methylene-bridged dimers (MZD) and other process impurities; piperazine nitrogen is readily oxidized to N-oxides; amide/indolin-2-one moieties are prone to hydrolysis under alkaline conditions; under light and peroxide conditions, the indolin-2-one skeleton is prone to cleavage, making related substance method development highly challenging.
[Sinco Provides] A cumulative total of 30 related impurity structures, with full sets of structural confirmation spectra available (including COA, NMR, MS, HPLC, etc.), supporting impurity profiling and method development. For the complete impurity list, see [Read More] at the end of this article.
SGAs: Paliperidone Impurities
[Common Challenges] Contains chiral centers, requiring high enantiomeric purity control; the 9-position hydroxyl is easily oxidized to the 9-keto impurity; side chains and the pyrimidinone ring are prone to side reactions under alkaline conditions, and degradation impurities such as ring opening and dealkylation may appear during formulation, generating degradant impurities.
[Sinco Provides] A cumulative total of 73 paliperidone-related impurity structures, with full sets of analytical spectra available, providing compliant reference standard support for enantiomeric purity control and impurity quantification. For the complete impurity list, see [Read More] at the end of this article.
Why Choose Sinco?
✅ Compliance Foundation: CQC certification + full structural confirmation spectra, with a complete data chain.
✅ Independent Synthesis: 30,000+ self-developed library, overcoming high-difficulty impurity customization.
✅ Efficient Delivery: 24-hour response, spot stock delivered within 2–4 business days, trusted in 40 countries worldwide.
Scroll down for more new products